Page last updated: 2024-11-02

phenylbutazone and Blindness

phenylbutazone has been researched along with Blindness in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mumenthaler, M1

Other Studies

1 other study available for phenylbutazone and Blindness

ArticleYear
[Polymyalgia rheumatica and its treatment].
    Deutsche medizinische Wochenschrift (1946), 1974, Sep-06, Volume: 99, Issue:36

    Topics: Alpha-Globulins; Arteritis; Biopsy; Blindness; Blood Sedimentation; Collagen Diseases; Giant Cell Ar

1974